Obalon Therapeutics, Inc.
Obalon Therapeutics, Inc. (OBLN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OBLN · as of Jun 9, 2026
Key Statistics
Explore Obalon Therapeutics, Inc. Data
obln stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 33.3%
Competitors & Peers
obln competitorsOBLN
FRTX
GBNH
LMDX
MDGS
NUVOStock Performance
Full HistoryAbout Obalon Therapeutics, Inc.
Obalon Therapeutics, Inc. operates as a fully integrated medical device enterprise, concentrating its efforts on creating and commercializing innovative solutions for individuals battling obesity. The…
what is obalon therapeutics, inc. · obln stock overview · obalon therapeutics, inc. company profile · who is obalon therapeutics, inc. ceo · obln NASDAQ · obalon therapeutics, inc. headquarters · obalon therapeutics, inc. business segments
About Stock Overview & Key Data
Obalon Therapeutics, Inc. (OBLN) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Oct 6, 2016. As of the latest trading session, OBLN stock price is $3.05, with a market capitalization of $5.5M. The stock has returned +152.07% over the past 12 months and +0.00% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Obalon Therapeutics, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Obalon Therapeutics, Inc. reported revenue of $319714.00 and net income of -$10.5M. For detailed data — including Obalon Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Obalon Therapeutics, Inc. (OBLN) stock price is $3.05. The stock is traded on NASDAQ under the ticker symbol OBLN. The 52-week range is $2.95 – $4.80.